Skin Toxicity in Patients With Metastatic Colorectal Cancer Treated With Anti-EGFR and Chemotherapy (DERMIA)

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

May 10, 2018

Primary Completion Date

April 6, 2020

Study Completion Date

April 6, 2020

Conditions
Skin Toxicity
Interventions
DRUG

Doxycycline 50Mg Tablet

Doxycycline administered p.o once daily at a 50 mg dose for 6 weeks beginning on Day -1

Trial Locations (8)

Unknown

Hospital Punta Europa, Algeciras

Hospital Puerta del Mar, Cadiz

Hospital Puerto Real, Cadiz

Hospital San Pedro de Alcántara, Cáceres

Hospital Clinico San Cecilio, Granada

Hospital Juan Ramón Jiménez, Huelva

Hospital de Jerez, Jerez de la Frontera

Hospital Virgen Macarena, Seville

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Amgen

INDUSTRY

collaborator

Apices Soluciones S.L.

INDUSTRY

lead

Fundacion CRIS de Investigación para Vencer el Cáncer

OTHER

NCT03448731 - Skin Toxicity in Patients With Metastatic Colorectal Cancer Treated With Anti-EGFR and Chemotherapy (DERMIA) | Biotech Hunter | Biotech Hunter